VER-246608

1684386-71-7

C28H23ClF2N4O4

DMSO : 100 mg/mL (180.84 mM; Need ultrasonic)

Metabolic Enzyme/Protease

VER-246608 is a potent and ATP-competitive inhibitor of pyruvate dehydrogenase kinase (PDK) with IC₅₀s of 35 nM, 40 nM, 84 nM, and 91 nM for PDK-1, PDK-3, PDK-2, and PDK-4, respectively. IC50 & Target: IC50: 35 nM (PDK-1), 40 nM (PDK-3), 84 nM (PDK-2), 91 nM (PDK-4)^[1] In Vitro: VER-246608 is a novel pan-isoform ATP competitive inhibitor of PDK. VER-246608 demonstrates similar potency across all four PDK isoforms in a DELFIA-based enzyme functional assay in the sub 100 nM range. In terms of cellular biomarker modulation, VER-246608 suppresses the phosphorylation of the Ser²⁹³ residue of E1alpha (phosphorylated by all four PDK isozymes) with IC₅₀ values of 266 nM. Treatment of PC-3 cells with 9 uM and 27 uM VER-246608 results in a 21% and 42% reduction, respectively, in media L-lactate levels following a 1 h incubation. VER-246608 also decreases D-glucose consumption at the same concentrations that result in reduced L-lactate production. An approximately 50% reduction in spheroid volume is achieved at concentrations of 10 uM and above, suggesting an increase in VER-246608 potency compared to monolayer growth^[1].